Article
NS5A inhibitor resistance-associated polymorphisms in Brazilian treatment-naive patients infected with genotype 1 hepatitis C virus.
The Journal of antimicrobial chemotherapy - 1 Mar 2015
Peres-da-Silva Allan, de Almeida Adilson José, Lampe Elisabeth
Abstract excerpt
OBJECTIVES: Several promising NS5A protein inhibitors for hepatitis C virus (HCV) treatment, showing good antiviral activity, are currently being evaluated in clinical trials. However, viral breakthroughs associated with resistant variants have been observed, especially in patients infected with HCV-1a. We aimed to evaluate the occurrence of potential resistance mutations in the NS5A gene of HCV among Brazilian...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
